Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018, Article ID 1942193, 10 pages
https://doi.org/10.1155/2018/1942193
Research Article

A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis

1Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany
2Clinic for Anesthesiology, Intensive Care, Emergency Medicine I and Pain Therapy, Westpfalz Hospital, Kaiserslautern, Germany

Correspondence should be addressed to Aleksandar R. Zivkovic; ed.grebledieh-inu.dem@civokviz.radnaskela

Received 25 January 2018; Accepted 19 March 2018; Published 29 April 2018

Academic Editor: Danilo Vojvodic

Copyright © 2018 Aleksandar R. Zivkovic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. K. J. Adhikari, R. A. Fowler, S. Bhagwanjee, and G. D. Rubenfeld, “Critical care and the global burden of critical illness in adults,” The Lancet, vol. 376, no. 9749, pp. 1339–1346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Pierrakos and J. L. Vincent, “Sepsis biomarkers: a review,” Critical Care, vol. 14, no. 1, article R15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. O. Ghanem-Zoubi, M. Vardi, A. Laor, G. Weber, and H. Bitterman, “Assessment of disease-severity scoring systems for patients with sepsis in general internal medicine departments,” Critical Care, vol. 15, no. 2, article R95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. D. Sekulic, S. V. Trpkovic, A. P. Pavlovic, O. M. Marinkovic, and A. N. Ilic, “Scoring systems in assessing survival of critically ill ICU patients,” Medical Science Monitor, vol. 21, pp. 2621–2629, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Vincent and R. Moreno, “Clinical review: scoring systems in the critically ill,” Critical Care, vol. 14, no. 2, p. 207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Andersson and K. J. Tracey, “Neural reflexes in inflammation and immunity,” Journal of Experimental Medicine, vol. 209, no. 6, pp. 1057–1068, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Czura and K. J. Tracey, “Autonomic neural regulation of immunity,” Journal of Internal Medicine, vol. 257, no. 2, pp. 156–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Andersson and K. J. Tracey, “Reflex principles of immunological homeostasis,” Annual Review of Immunology, vol. 30, no. 1, pp. 313–335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. J. Tracey, “Reflex control of immunity,” Nature reviews Immunology, vol. 9, no. 6, pp. 418–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. K. J. Tracey, “Physiology and immunology of the cholinergic antiinflammatory pathway,” The Journal of Clinical Investigation, vol. 117, no. 2, pp. 289–296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. K. J. Tracey, “The inflammatory reflex,” Nature, vol. 420, no. 6917, pp. 853–859, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Darvesh, D. A. Hopkins, and C. Geula, “Neurobiology of butyrylcholinesterase,” Nature Reviews Neuroscience, vol. 4, no. 2, pp. 131–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. R. Zivkovic, K. Schmidt, A. Sigl, S. O. Decker, T. Brenner, and S. Hofer, “Reduced serum butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients,” Mediators of Inflammation, vol. 2015, Article ID 274607, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. G. M. do Carmo, L. Z. Crivellenti, N. B. Bottari et al., “Butyrylcholinesterase as a marker of inflammation and liver injury in the acute and subclinical phases of canine ehrlichiosis,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 43, pp. 16–21, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. H. Zhang, A. M. Li, S. L. He et al., “Serum total cholinesterase activity on admission is associated with disease severity and outcome in patients with traumatic brain injury,” PLoS One, vol. 10, no. 6, article e0129082, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Distelmaier, M. P. Winter, K. Rützler et al., “Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery,” Critical Care, vol. 18, no. 1, article R24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. G. A. Reid, N. Chilukuri, and S. Darvesh, “Butyrylcholinesterase and the cholinergic system,” Neuroscience, vol. 234, pp. 53–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Lampón, E. F. Hermida-Cadahia, A. Riveiro, and J. C. Tutor, “Association between butyrylcholinesterase activity and low-grade systemic inflammation,” Annals of Hepatology, vol. 11, no. 3, pp. 356–363, 2012. View at Google Scholar
  20. K. Ofek, K. S. Krabbe, T. Evron et al., “Cholinergic status modulations in human volunteers under acute inflammation,” Journal of Molecular Medicine, vol. 85, no. 11, pp. 1239–1251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. Zivkovic, J. Bender, T. Brenner, S. Hofer, and K. Schmidt, “Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response,” Journal of Inflammation Research, vol. 9, pp. 221–230, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. S. O. Decker, A. Sigl, C. Grumaz et al., “Immune-response patterns and next generation sequencing diagnostics for the detection of mycoses in patients with septic shock—results of a combined clinical and experimental investigation,” International Journal of Molecular Sciences, vol. 18, no. 8, article 1796, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. R. P. Dellinger, M. M. Levy, A. Rhodes et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock,” Critical Care Medicine, vol. 41, no. 2, pp. 580–637, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. B. Pepys and G. M. Hirschfield, “C-reactive protein: a critical update,” Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805–1812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Welsch, K. Frommhold, U. Hinz et al., “Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications,” Surgery, vol. 143, no. 1, pp. 20–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. P. Castelli, C. Pognani, M. Cita, A. Stuani, L. Sgarbi, and R. Paladini, “Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis,” Minerva anestesiologica, vol. 72, no. 1-2, pp. 69–80, 2006. View at Google Scholar
  27. A. C. M. Kobold, J. E. Tulleken, J. G. Zijlstra et al., “Leukocyte activation in sepsis; correlations with disease state and mortality,” Intensive Care Medicine, vol. 26, no. 7, pp. 883–892, 2000. View at Publisher · View at Google Scholar
  28. K. Tschaikowsky, M. Hedwig-Geissing, G. G. Braun, and M. Radespiel-Troeger, “Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis,” Journal of Critical Care, vol. 26, no. 1, pp. 54–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. R. F. Mortensen, “C-Reactive protein, inflammation, and innate immunity,” Immunologic Research, vol. 24, no. 2, pp. 163–176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. G. P. Castelli, C. Pognani, M. Meisner, A. Stuani, D. Bellomi, and L. Sgarbi, “Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction,” Critical Care, vol. 8, no. 4, article R234, 2004. View at Publisher · View at Google Scholar
  31. J. Cohen, “The immunopathogenesis of sepsis,” Nature, vol. 420, no. 6917, pp. 885–891, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. T. S. Blackwell and J. W. Christman, “Sepsis and cytokines: current status,” British Journal of Anaesthesia, vol. 77, no. 1, pp. 110–117, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Dama, D. Ledoux, M. Nys et al., “Cytokine serum level during severe sepsis in human IL-6 as a marker of severity,” Annals of Surgery, vol. 215, no. 4, pp. 356–362, 1992. View at Publisher · View at Google Scholar
  34. C. A. Gogos, E. Drosou, H. P. Bassaris, and A. Skoutelis, “Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options,” The Journal of Infectious Diseases, vol. 181, no. 1, pp. 176–180, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Oberholzer, S. M. Souza, S. K. Tschoeke et al., “Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis,” Shock, vol. 23, no. 6, pp. 488–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. F. A. Bozza, J. I. Salluh, A. M. Japiassu et al., “Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis,” Critical Care, vol. 11, no. 2, pp. R49–R48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Andaluz-Ojeda, F. Bobillo, V. Iglesias et al., “A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis,” Cytokine, vol. 57, no. 3, pp. 332–336, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Linscheid, D. Seboek, H. Zulewski, U. Keller, and B. Müller, “Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue,” Endocrinology, vol. 146, no. 6, pp. 2699–2708, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Christ-Crain, N. G. Morgenthaler, J. Struck, S. Harbarth, A. Bergmann, and B. Müller, “Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study,” Critical Care, vol. 9, article R816, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. V. de la Torre-Prados, A. Garcia-De La Torre, A. Enguix, M. Mayor-Reyes, M. Nieto-González, and A. Garcia-Alcantara, “Mid-regional pro-adrenomedullin as prognostic biomarker in septic shock,” Minerva Anestesiologica, vol. 82, pp. 760–766, 2016. View at Google Scholar
  41. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II: a severity of disease classification system,” Critical care medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  42. J. R. Le Gall, S. Lemeshow, and F. Saulnier, “A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study,” JAMA, vol. 270, no. 24, pp. 2957–2963, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. J. L. Vincent, R. Moreno, J. Takala et al., “The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure,” Intensive Care Medicine, vol. 22, no. 7, pp. 707–710, 1996. View at Publisher · View at Google Scholar
  44. H. Wang, M. Yu, M. Ochani et al., “Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation,” Nature, vol. 421, no. 6921, pp. 384–388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. J. E. Blalock, “The immune system as the sixth sense,” Journal of Internal Medicine, vol. 257, no. 2, pp. 126–138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. J. E. Blalock, “The immune system as a sensory organ,” The Journal of immunology, vol. 132, no. 3, pp. 1067–1070, 1984. View at Google Scholar
  47. L. V. Borovikova, S. Ivanova, M. Zhang et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, no. 6785, pp. 458–462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. L. E. Goehler, R. P. A. Gaykema, M. K. Hansen, K. Anderson, S. F. Maier, and L. R. Watkins, “Vagal immune-to-brain communication: a visceral chemosensory pathway,” Autonomic Neuroscience: Basic & Clinical, vol. 85, no. 1-3, pp. 49–59, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. V. A. Pavlov, H. Wang, C. J. Czura, S. G. Friedman, and K. J. Tracey, “The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation,” Molecular medicine, vol. 9, no. 5-8, pp. 125–134, 2003. View at Google Scholar
  50. M. Pohanka, “Butyrylcholinesterase as a biochemical marker,” Bratislava Medical Journal, vol. 114, no. 12, pp. 726–734, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Santarpia, I. Grandone, F. Contaldo, and F. Pasanisi, “Butyrylcholinesterase as a prognostic marker: a review of the literature,” Journal of Cachexia, Sarcopenia and Muscle, vol. 4, no. 1, pp. 31–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Meng, X. Yin, X. Ma, X.-D. Guo, B. Jin, and H. Li, “Assessment of the value of serum cholinesterase as a liver function test for cirrhotic patients,” Biomedical Reports, vol. 1, no. 2, pp. 265–268, 2013. View at Publisher · View at Google Scholar